logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Boehringer Ingelheim's new generation thrombolytic drug Meltingin has been approved in China for the treatment of acute ischemic stroke.

date
21/05/2025
Boehringer Ingelheim announced that the China National Medical Products Administration has officially approved Meetingl for the treatment of acute ischemic stroke within 4.5 hours of onset.
Latest
3 m ago
Economic Information Daily reported that on May 21st, Huajin Securities issued a research report giving a buy rating on Lianlong (300596.SZ). The reasons for the rating mainly include: 1) the market share and gross profit margin of the high molecular anti-aging business have both increased year-on-year; 2) the operating rate of lubricant additives has increased, and the initial results of developing major customers have been seen; 3) the technology of life science products is gradually maturing, transitioning from research and development to dual-track operation of research and development and marketing; 4) the future prospects of emerging businesses are promising.
3 m ago
Partial US quantum computing concept stocks surged again today, with Arqit Quantum rising by over 21%, SEALSQ Corp by over 15%, and Google A by over 4%.
3 m ago
Each AI Express news, Huajin Securities released a research report on May 21, giving Sailun Tire (601058.SH) a buy rating. The rating reasons mainly include: 1) continuous improvement in production and sales, and stable performance; 2) orderly promotion of global layout, strengthening product and brand shaping. (Daily Economic News)
3 m ago
According to the AI Quick News of Every Business, Huajin Securities issued a research report on May 21, giving a buy rating to Jinshi Resources (603505.SH). The reasons for the rating mainly include: 1) the lithium business and self-owned mines hindered the performance of 2024, but the situation improved in Q1 2025; 2) outstanding resource scale and industry chain advantages. (Daily Economic News)
3 m ago
According to the AI Express News, Huaxin Securities released a research report on May 21, giving a buy rating to Nanshan Technology (688484.SH). The reasons for the rating include: 1) Rapid growth in annual revenue, with various downstream areas flourishing; 2) The company's expansion in downstream areas has been effective, continuously strengthening its competitive advantage. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.